

Suboxone®, a medication commonly prescribed for opioid addiction, has been hailed as a lifesaver for many individuals.
In October 2002, the Food and Drug Administration (FDA) approved two buprenorphine products (Suboxone® and Subutex®)1 for the treatment of narcotic addiction. Both products are high dose (2 mg and 8 mg) sublingual (under the tongue) tablets.
Buprenorphine is categorized as a Schedule III drug, which means it has a moderate-to-low potential for physical dependence or a high potential for psychological dependence. Source: https://www.ncbi.nlm.nih.gov/books/NBK459126/
"*" indicates required fields
It works by effectively curbing cravings and prevents users from getting high on other dangerous drugs. However, recent discoveries have revealed a concerning link between Suboxone® and severe tooth decay, leading to a rise in Suboxone tooth decay lawsuits. If you or someone you know has experienced dental issues while on Suboxone®, you may be entitled to compensation through a Suboxone lawsuit payout per person. The Schmidt National Law Group is now accepting these cases, contact us using the secure form on this page or call direct at 1-800-631-5656 to discuss your legal options and potential Suboxone settlement amounts.
In recent years, the number of lawsuits filed against Indivior, the manufacturer of Suboxone®, has skyrocketed due to claims of tooth decay caused by the drug.
As of November 2023, over 100 lawsuits have been filed, with 14 new cases added just this month. Given the widespread use of Suboxone® and the increasing awareness of dental problems associated with it, this number is expected to rise even further. Indivior may face legal consequences and potential financial liabilities as these lawsuits continue to accumulate.
On November 30, 2023, a group of lawyers representing plaintiffs filed a petition with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federal Suboxone® lawsuits into a multidistrict litigation (MDL). The United States District Court for the Northern District of Ohio, where a majority of the lawsuits have been filed, is the likely jurisdiction for the forthcoming Suboxone® tooth decay lawsuits MDL. This MDL process aims to streamline the legal proceedings and potentially lead to a global Suboxone settlement for plaintiffs who have suffered dental injuries.
Suboxone® is widely considered the gold standard for opioid addiction treatment. While some individuals may experience side effects such as nausea, headaches, and constipation, it is important to pay attention to any potential dental issues, particularly tooth decay, and consult with a doctor if necessary. The Suboxone sublingual film formulation has also been associated with oral health issues like xerostomia (dry mouth) and dental caries.
Suboxone® is a medication that assists individuals struggling with opioid addiction by making it easier for them to stop using harmful drugs. It functions by binding to the same receptors in the brain that opioids attach to, but without producing a euphoric effect. This helps reduce cravings and withdrawal symptoms, facilitating the recovery process from opioid dependence or addiction.
The use of Suboxone® has been linked to various dental health problems, causing significant distress among those prescribed the medication. Some of the most commonly reported dental issues in Suboxone lawsuits teeth include:
Addressing these dental injuries often entails painful and expensive procedures. If you have experienced dental problems related to Suboxone® use, it is crucial to seek professional legal assistance, from the Schmidt National Law Group, to explore your rights and potential cash compensation through a Suboxone lawsuit payout.
Suboxone class action lawsuits filed against Indivior claim that the company failed to adequately warn individuals about the risks of severe tooth decay associated with Suboxone® use. Plaintiffs argue that Indivior either knew or should have known about these risks but did not take sufficient action to prevent them, amounting to a failure to warn consumers about potential dental injuries.
The connection between Suboxone® use and tooth decay is based on both patient reports and scientific observations. While more research is needed to establish a definitive link, the following evidence has been highlighted in Suboxone tooth decay lawsuits:
Several studies have explored the relationship between Suboxone® use and tooth decay, with some suggesting an increased risk of dental problems. In 2022, the FDA issued a warning regarding the risk of dental injuries associated with buprenorphine-containing medications, including Suboxone®. Some individuals experienced severe oral issues such as tooth decay, cavities, infections, and tooth loss, even if they had previously maintained good dental hygiene. As a result, the FDA mandated that manufacturers like Indivior include warnings about these dental risks in the prescribing information and patient medication guide.
In 2022, the FDA issued a warning regarding the risk of dental problems associated with buprenorphine-containing medications, including Suboxone®. Some individuals experienced severe oral issues such as tooth decay, cavities, infections, and tooth loss, even if they had previously maintained good dental hygiene. As a result, the FDA mandated that manufacturers include warnings about these dental risks in the prescribing information and patient medication guide.
Individuals who have suffered from severe dental problems or other oral health issues due to Suboxone® use may be eligible for cash compensation from settlements through a Suboxone class action lawsuit payout per person.
The amount of compensation in a Suboxone lawsuit payout depends on the extent of dental damage and the specific details of each case. Possible compensation may cover economic damages like medical and dental bills, lost wages, and future dental treatments, as well as non-economic damages for pain and suffering. The Schmidt National Law Group specializes in assisting individuals seeking compensation for dental injuries caused by Suboxone® and has a proven track record in product liability litigation against major pharmaceutical companies like Indivior.
To determine if you qualify to join a Suboxone class action lawsuit 2023 payout, it is important to consult with our licensed attorneys experienced in handling Suboxone® cases. We can evaluate your situation, discuss your legal options, and guide you through the process of seeking a Suboxone settlement. Keep in mind that each state has its own statute of limitations for filing product liability lawsuits, so it’s crucial to act promptly to protect your rights.
As the Suboxone lawsuits 2023 progress and the potential MDL unfolds, we may see bellwether trials that help establish Suboxone settlement amounts for plaintiffs. If you’re wondering how much you could get from a Suboxone settlement or when you might receive compensation, the best step is to contact the Schmidt National Law Group for a free consultation.
Call direct at 1-800-631-5656 or use the 100% secure web form on this page to discuss your potential Suboxone lawsuit payout per person.
Sources:
https://www.ncbi.nlm.nih.gov/books/NBK459126/
https://www.fda.gov/search?s=Suboxone
Page: Suboxone Tooth Decay Lawsuit & Claims updated on August 20, 2023.